Cargando…

Spray-Dried Formulation of Epicertin, a Recombinant Cholera Toxin B Subunit Variant That Induces Mucosal Healing

Epicertin (EPT) is a recombinant variant of the cholera toxin B subunit, modified with a C-terminal KDEL endoplasmic reticulum retention motif. EPT has therapeutic potential for ulcerative colitis treatment. Previously, orally administered EPT demonstrated colon epithelial repair activity in dextran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reeves, Micaela A., Royal, Joshua M., Morris, David A., Jurkiewicz, Jessica M., Matoba, Nobuyuki, Hamorsky, Krystal T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073836/ https://www.ncbi.nlm.nih.gov/pubmed/33919585 http://dx.doi.org/10.3390/pharmaceutics13040576

Ejemplares similares

Cholera Toxin B: One Subunit with Many Pharmaceutical Applications
por: Baldauf, Keegan J., et al.
Publicado: (2015)

Repeated Oral Administration of a KDEL-Tagged Recombinant Cholera Toxin B Subunit Effectively Mitigates DSS Colitis despite a Robust Immunogenic Response
por: Royal, Joshua M., et al.
Publicado: (2019)

N-Glycosylation of cholera toxin B subunit in Nicotiana benthamiana: impacts on host stress response, production yield and vaccine potential
por: Hamorsky, Krystal Teasley, et al.
Publicado: (2015)

Rapid and Scalable Plant-based Production of a Cholera Toxin B Subunit Variant to Aid in Mass Vaccination against Cholera Outbreaks
por: Hamorsky, Krystal Teasley, et al.
Publicado: (2013)

Therapeutic Potential of Cholera Toxin B Subunit for the Treatment of Inflammatory Diseases of the Mucosa
por: Royal, Joshua M., et al.
Publicado: (2017)

N-Glycosylation of Cholera Toxin B Subunit: Serendipity for Novel Plant-Made Vaccines?
por: Matoba, Nobuyuki
Publicado: (2015)

Characterization and utility of two monoclonal antibodies to cholera toxin B subunit
por: Verjan Garcia, Noel, et al.
Publicado: (2023)

Bulk production of the antiviral lectin griffithsin
por: Fuqua, Joshua L., et al.
Publicado: (2015)

Simultaneous Spray Drying for Combination Dry Powder Inhaler Formulations
por: Shepard, Kimberly B., et al.
Publicado: (2022)

Developments in the formulation and delivery of spray dried vaccines
por: Kanojia, Gaurav, et al.
Publicado: (2017)

Hydroponic Treatment of Nicotiana benthamiana with Kifunensine Modifies the N-glycans of Recombinant Glycoprotein Antigens to Predominantly Man9 High-Mannose Type upon Transient Overexpression
por: Roychowdhury, Sugata, et al.
Publicado: (2018)

A novel anti‐HIV‐1 bispecific bNAb‐lectin fusion protein engineered in a plant‐based transient expression system
por: Seber Kasinger, Lauren E., et al.
Publicado: (2019)

Safety and Efficacy of Avaren-Fc Lectibody Targeting HCV High-Mannose Glycans in a Human Liver Chimeric Mouse Model
por: Dent, Matthew, et al.
Publicado: (2020)

Spray Dried Formulations for Inhalation—Meaningful Characterisation of Powder Properties
por: Jüptner, Angelika, et al.
Publicado: (2019)

Development of Inhalable Spray Dried Nitrofurantoin Formulations for the Treatment of Emphysema
por: Leslie, Mathew N., et al.
Publicado: (2022)

Production of Pentameric Cholera Toxin B Subunit in Escherichia coli
por: Dakterzada, Farida, et al.
Publicado: (2012)

Preparation of cholera toxin subunit-B for use in vaccine preparation
Publicado: (1986)

Evaluation of nano spray drying as a method for drying and formulation of therapeutic peptides and proteins
por: Haggag, Yusuf A., et al.
Publicado: (2015)

Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain
por: Shim, Byoung-Shik, et al.
Publicado: (2018)

Influence of Solvent Composition on the Performance of Spray-Dried Co-Amorphous Formulations
por: Mishra, Jaya, et al.
Publicado: (2018)

Characterization of Amorphous and Co-Amorphous Simvastatin Formulations Prepared by Spray Drying
por: Craye, Goedele, et al.
Publicado: (2015)

Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy
por: Shao, Zitong, et al.
Publicado: (2021)

A Protein-Based Pentavalent Inhibitor of the Cholera Toxin B-Subunit**
por: Branson, Thomas R, et al.
Publicado: (2014)

Cholera toxin B subunit induces local curvature on lipid bilayers
por: Pezeshkian, Weria, et al.
Publicado: (2017)

Anti-inflammatory effect of cholera toxin B subunit in experimental stroke
por: Zhang, Lei, et al.
Publicado: (2016)

Immunization with Cholera Toxin B Subunit Induces High-Level Protection in the Suckling Mouse Model of Cholera
por: Price, Gregory A., et al.
Publicado: (2013)

A Conformational Shift in the Dissociated Cholera Toxin A1 Subunit Prevents Reassembly of the Cholera Holotoxin
por: Taylor, Michael, et al.
Publicado: (2015)

A Therapeutic Chemical Chaperone Inhibits Cholera Intoxication and Unfolding/Translocation of the Cholera Toxin A1 Subunit
por: Taylor, Michael, et al.
Publicado: (2011)

Formulation of inhalable lipid-based salbutamol sulfate microparticles by spray drying technique
por: Daman, Zahra, et al.
Publicado: (2014)

Topical Formulation of Nano Spray-Dried Levocetirizine Dihydrochloride against Allergic Edema
por: Mirankó, Mirella, et al.
Publicado: (2022)

Cholera Toxin Subunit B for Sensitive and Rapid Determination of Exosomes by Gel Filtration
por: Sapoń, Karolina, et al.
Publicado: (2020)

The Functions of Cholera Toxin Subunit B as a Modulator of Silica Nanoparticle Endocytosis
por: Susnik, Eva, et al.
Publicado: (2023)

Novel Mucosal DNA-MVA HIV Vaccination in Which DNA-IL-12 Plus Cholera Toxin B Subunit (CTB) Cooperates to Enhance Cellular Systemic and Mucosal Genital Tract Immunity
por: Maeto, Cynthia, et al.
Publicado: (2014)

Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin
por: Kim, Donghyun, et al.
Publicado: (2016)

Nasal Administration of Cholera Toxin as a Mucosal Adjuvant Damages the Olfactory System in Mice
por: Fukuyama, Yoshiko, et al.
Publicado: (2015)

Preparation and In vitro / In vivo characterization of spray dried microsphere formulation encapsulating 4-chlorocurcumin
por: Gogu, P. K., et al.
Publicado: (2010)

Formulation Development, Process Optimization, and In Vitro Characterization of Spray-Dried Lansoprazole Enteric Microparticles
por: Vora, Chintan, et al.
Publicado: (2016)

Optimization and characterization of spray-dried IgG formulations: a design of experiment approach
por: Faghihi, Homa, et al.
Publicado: (2017)

Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous Formulations
por: Kasten, Georgia, et al.
Publicado: (2019)

Superiority of Mesoporous Silica-Based Amorphous Formulations over Spray-Dried Solid Dispersions
por: Zhang, Hongwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3pa6sceio98iiug714onlq6dd8